Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
Public ClinicalTrials.gov record NCT02317627. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Open-Label, Dose-finding Study to Evaluate the Safety, Tolerability, and Activity of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy
Study identification
- NCT ID
- NCT02317627
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Kadmon Corporation, LLC
- Industry
- Enrollment
- 38 participants
Conditions and interventions
Conditions
Interventions
- KD025 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2014
- Primary completion
- Feb 29, 2016
- Completion
- Feb 29, 2016
- Last update posted
- May 25, 2022
2014 – 2016
United States locations
- U.S. sites
- 9
- U.S. states
- 9
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arrowhead Health Centers | Glendale | Arizona | 85306 | — |
| Southern California Dermatology, Inc. | Santa Ana | California | 92701 | — |
| Shondra L. Smith | Lake Charles | Louisiana | 70605 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
| Clinical Studies Group, LLC | Henderson | Nevada | 89074 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10029 | — |
| High Point Clinical Trials Center | High Point | North Carolina | 27265 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Metroplex Clinical Research Center (MCRC) | Dallas | Texas | 75231 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02317627, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 25, 2022 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02317627 live on ClinicalTrials.gov.